Literature DB >> 18323672

Significant association of serum albumin with severity of retinopathy and neuropathy, in addition to that of nephropathy, in Japanese type 2 diabetic patients.

Tomoyuki Iwasaki1, Yu Togashi, Yasuo Terauchi.   

Abstract

OBJECTIVE: The aim of this study was to determine the association between serum albumin and the severity of microvascular complications and presence of coronary artery disease in type 2 diabetic patients. PATIENTS AND METHODS: The presence of diabetic complications was assessed in a total of 130 Japanese patients with type 2 diabetes mellitus. Retinopathy was classified as absent, simple or proliferative diabetic retinopathy. Neuropathy was considered to be present when the patient showed absence of Achilles tendon reflex, and also evaluated by measuring the median motor nerve conduction velocity (MNCV) in the nerve conduction study.
RESULTS: In relation to retinopathy, there were 83 patients with no retinopathy (absent), 26 with simple retinopathy and 21 with proliferative retinopathy. There was a significant difference in the serum albumin level between the "absent" group and the other two groups. In relation to nephropathy, there were 68 patients with no evidence of nephropathy, 49 with microalbuminuria and 13 with proteinuria. The results of logistic regression analysis with adjustment for three variables (age, gender, serum CRP) revealed that serum albumin was independently related to proliferative retinopathy and proteinuria. In relation to neuropathy, serum albumin was found to be significantly related to the absence of Achilles tendon reflex, MNCV, and MFWL. The results of multiple regression analysis with adjustment for three variables (age, gender, serum CRP) revealed that serum albumin was independently related to MNCV and MFWL.
CONCLUSIONS: Serum albumin was significantly associated with the severity of retinopathy and neuropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323672     DOI: 10.1507/endocrj.k07-086

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Serum albumin is associated with peripheral nerve function in patients with type 2 diabetes.

Authors:  Lu Li; Bo Liu; Jingyi Lu; Lan Jiang; Yinan Zhang; Yingdi Shen; Congrong Wang; Weiping Jia
Journal:  Endocrine       Date:  2015-04-10       Impact factor: 3.633

2.  The correlation between serum albumin and diabetic retinopathy among people with type 2 diabetes mellitus: NHANES 2011-2020.

Authors:  Gao-Xiang Wang; Ze-Bin Fang; Jun-Tong Li; Bao-Li Huang; De-Liang Liu; Shu-Fang Chu; Hui-Lin Li
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

3.  Correlation of morphological pattern of optical coherence tomography in diabetic macular edema with systemic risk factors in middle aged males.

Authors:  Sambuddha Ghosh; Preeti Bansal; Harsha Shejao; Raghuraj Hegde; Debesh Roy; Shyamapada Biswas
Journal:  Int Ophthalmol       Date:  2014-03-01       Impact factor: 2.031

4.  The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy.

Authors:  Junlin Zhang; Rui Zhang; Yiting Wang; Hanyu Li; Qianqian Han; Yucheng Wu; Tingli Wang; Fang Liu
Journal:  J Diabetes Res       Date:  2019-02-17       Impact factor: 4.011

5.  Association Between Serum Albumin Levels and Diabetic Peripheral Neuropathy Among Patients with Type 2 Diabetes: Effect Modification of Body Mass Index.

Authors:  Ying Hu; Jiancheng Wang; Sha Zeng; Mengxia Chen; Guilin Zou; Yuxia Li; Lingyan Zhu; Jixiong Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-22       Impact factor: 3.168

6.  Intake of Gnetum africanum and Dacryodes edulis, imbalance of oxidant/antioxidant status and prevalence of diabetic retinopathy in central Africans.

Authors:  Mvitu-Muaka Moise; Longo-Mbenza Benjamin; Mokondjimobe Etienne; Gombet Thierry; Kibokela Ndembe Dalida; Tulomba Mona Doris; Wayiza Masamba Samy
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.